First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease — Stella
First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(7 sites)
United States
Piedmont Healthcare, Inc., Atlanta, Georgia
Columbia University Medical Center/ NewYork Presbyterian Hospital or CUMC/NYPH, New York, New York
St Francis Hospital Heart Center, Roslyn, New York